The increase in oxidation markers produced in PD brains concurs with ApoA-I oxidative damage, resulting in malfunction of cholesterol processing, dysregulation of the inflammatory response, and acceleration of neurodegeneration. This evidence concerns the gene APOA1 and Parkinson disease.